Serum Proteomic Profile of Asthmatic Patients after Six Months of Benralizumab and Mepolizumab Treatment.
Vantaggiato L, Cameli P, Bergantini L, d'Alessandro M, Shaba E, Carleo A, Di Giuseppe F, Angelucci S, Sebastiani G, Dotta F, Bini L, Bargagli E, Landi C.
Vantaggiato L, et al. Among authors: di giuseppe f.
Biomedicines. 2022 Mar 24;10(4):761. doi: 10.3390/biomedicines10040761.
Biomedicines. 2022.
PMID: 35453511
Free PMC article.